California Non-Local Sources CA

U.S. FDA approves UCB's drug for rare childhood epilepsy

Daily Mail on California

Mar 28, 2022

March 28 (Reuters) - Belgian biotech firm UCB SA said on Monday the U.S. Food and Drug Administration (FDA) approved its drug to treat seizures associated...

Read the full story at Daily Mail on California

Topics

#Biotech

U.S. FDA approves UCB's drug for rare childhood epilepsy

Topics

More from California Non-Local Sources

Life-sentenced rapist who called break-in attack his 'Super Bowl' wins early release after just a decade

FBI offers $1M reward for capture of 'Ten Most Wanted' 300-pound suspect possibly hiding in Mexico

California bishop's alleged secret double life explodes into felony case

At least 40 percent of California teachers plan to quit in the next decade: survey

California professor calls to abolish identities like 'gay' and 'lesbian' since they 'harm trans people'

California House Republican announces he's leaving GOP immediately, thinning slim majority

Former SJSU volleyball star opens up on living with trans teammate without knowing athlete's biological sex

Trump admin squashes controversial Biden rule forcing foster homes to affirm children's LGBTQ+ status

U.S. FDA approves UCB&#39;s drug for rare childhood epilepsy

Topics

More from California Non-Local Sources

U.S. FDA approves UCB's drug for rare childhood epilepsy